| Name | Major Symptoms | First Detection | Global Cases | Global Death Rate | Transmission | Affected groups | Treatments | Vaccines | End of Pandemic |
| 1918 Influenza | fever, nausea, aches, diarrhea | March 1918, NA | 500 million | nearly 2% | respiratory droplets | ages 20 - 40 | none | none | summer 1919 |
| Seasonal Flu | fever, sore throat, cough, fatigue | NA | 1 billion | 0.10% | respiratory droplets | older adults and immuno-compromised | Tamiflu, Relenza, Rapivab, Xofluza | available | NA |
| 2002-2004 SARS | fever, cough, malaise | November 2002, China | 8098 | 15% | respiratory droplets and contaminated surfaces | older individual >60 had higher death rate | antivirals and steroids | available | July 2003 |
| H1N1 Flu Pandemic | fever, chills, cough, body ache | 2009, Mexico and US | 60.8 million U.S cases | 0.02% | respiratory droplets | children between 5 - 19 | antivirals | available | August 2010 |
| Ebola | fever, aches, pain, diarrhea, weakness, vomiting | 2013, Guinea | 28,652 | 50% | bodily fluids like blood, sweat, feces and close contact | children | none | none | March 2016 |
| COVID-19 | unproductive cough, fever, shortness of breath, headache | December 2019, China | >4 million | 3.40% | unproductive cough, fever, shortness of breath, headache | adults over 60 and with underlying health conditions | none | none | NA |